에 대한 최신 뉴스 Darling Ingredients (NYSE:DAR) 주식

Darling Ingredients

Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.

Oil prices rise

Mid Cap

News

Movers

Trading Ideas

CIVI

NVDA

OKLO

QUBT

지난주 상승한 주요 중형주 중 대부분은 중동 갈등으로 인해 유가가 급등하면서 상승한 에너지 주식이었다.

오클로, 퀀텀 컴퓨팅 등 지난주 급등한 중형주 10종목 (6월 9일~13일)

Darling Ingredients Inc

Mines of Dalarnia - United States Dollar

Dare Bioscience Inc

Grizzle Growth ETF

DIGITAL ARTS INC by Digital Arts Inc.

WIIM

Darling Ingredients shares are trading higher after the company announced it launched a €750 million debt offering.

U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Monday.
Shares of Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) rose sharply during Monday's session after Supernus Pharmaceuticals <a href="https://www.benzinga.com/quote/SAGE">agreed to acquire the company</a>.
Supernus Pharmaceuticals on Monday agreed to acquire Sage Therapeutics for $12.00 per share in cash, or an aggregate of up to approximately $795 million.
The deal consideration includes $8.50 per share in cash (or an aggregate of approximately $561 million) plus one non-tradable contingent value right (CVR) collectively worth up to $3.50 per share in cash (or an aggregate of approximately $234 million).
Sage Therapeutics shares climbed 35.6% to $9.09 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) shares jumped 48.2% to $24.96 after President Trump reportedly urged Ergen and Carr to cut a deal on the company&#8217;s spectrum.</li>
<li>AIRO Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) jumped 42% to $31.11 after jumping 140% on Friday. AIRO Group priced its $60 million initial public offering of 6 million common shares at $10 per share.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) gained 22.1% to $163.13.</li>
<li>Arqit Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) rose 21% to $28.77.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 17.4% to $35.83. NANO Nuclear Energy announced that Matthew Barry has joined the Company as its Director of Investor Relations.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) rose 17.4% to $21.63.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) rose 17.1% to $5.08 after Korea Zinc announced an equity investment of $85.2 million in the company.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) climbed 17% to $14.05.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 15.6% to $19.17.</li>
<li>NextNav Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) gained 15.6% to $14.88.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 10.3% to $82.06 after the company announced a new integration with Amazon Ads.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) gained 10.2% to $61.17.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 10% to $42.21.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 9.8% to $6.87.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) rose 9.5% to $5.74.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) gained 9.1% to $39.28. Darling Ingredients announced offering of €750 Million of senior notes by Darling Global Finance B.V. and proposed entry into a new amended and restated credit agreement.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) rose 9% to $33.42.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) surged 8.5% to $126.01.</li>
<li>The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) gained 7.9% to $72.67.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) climbed 6% to $71.15. Marvell Technology announced a quarterly dividend of 6 cents per share of common stock.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45946608/top-3-materials-stocks-that-could-blast-off-this-month-3">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

AIRO

ARQQ

ASTS

CRCL

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MRVL

ROKU

SAGE

SATS

TSSI

URGN

Sage Therapeutics, Roku, EchoStar And Other Big Stocks Moving Higher On Monday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.darlingii.com%2F&amp;esheet=54276132&amp;newsitemid=20250613534574&amp;lan=en-US&amp;anchor=Darling+Ingredients+Inc.&amp;index=1&amp;md5=bf2c7237cfd2ee8c51ba1e89137db9da">Darling Ingredients Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) ("Darling" or the "Company") the world's leading company turning food waste into sustainable products and producer of renewable energy today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly owned subsidiary of the Company incorporated as a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) under Dutch law, has launched an offering of €750 million in aggregate principal amount of its senior notes (the "notes"). In addition, the Company announces that it intends to amend and restate its Second Amended and Restated Credit Agreement, dated as of January 6, 2014 (as amended from time to time), pursuant to a Third Amended and Restated Credit Agreement.
The notes will be guaranteed by the Company and the Company's restricted subsidiaries that will be borrowers under or that will guarantee the Company's senior secured credit facilities under the proposed Third Amended and Restated Credit Agreement, other than foreign subsidiaries, receivables entities and certain other subsidiaries. The offering is subject to market and other conditions.
The Company intends to use the proceeds from the offering of the notes, together with the drawings under the proposed senior secured credit facilities, to (i) redeem the Issuer's €515.0 million principal amount of the 3.625% Senior Notes due 2026 issued under the indenture dated May 2, 2018 and repay certain of the existing senior secured credit facilities; and (ii) pay costs, fees and expenses related to the refinancing, including applicable premiums for the refinancing and the issuance discount for the initial purchasers.

Offerings

Darling Ingredients Launches €750M Debt Offering to Refinance Loans and Strengthen Renewable Energy Push

Among the top mid-cap stocks that gained last week, most were energy stocks, driven by a spike in oil prices fueled by the Middle East conflict.
<ol class="wp-block-list">
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) stock rose 26.59% after the company was issued a <a href="https://www.benzinga.com//node/45909275">Notice of Intent</a> to Award by the Defense Logistics Agency Energy to provide clean power through its Aurora powerhouse for a U.S. Air Force site. It also raised $400 million via an equity offering, and several analysts increased their <a href="https://www.benzinga.com/quote/OKLO/analyst-ratings">price forecasts on the stock</a>.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) stock increased 25.63% last week.</li>
<li>Quantum Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock climbed 21.75% last week after Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang <a href="https://www.benzinga.com//node/45889749">commented that quantum computers</a> will soon solve real-world problems beyond classical computing, boosting interest in quantum-linked stocks.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) stock gained 20.29% last week due to rising oil prices amid heightened geopolitical tensions in the Middle East.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) stock rose 18.87% last week after reports that the Trump administration <a href="https://www.benzinga.com//node/45846703">plans to invoke Cold War-era</a> powers to accelerate rare earth projects.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) stock increased 18.48% last week.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) gained rose 17.11% last week.</li>
<li>Civitas Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) stock increased 16.77% last week following energy sector momentum driven by surging oil prices and Middle East instability.</li>
<li>PBF Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) stock rose 15.41% last week after energy stocks rallied amid rising crude prices and geopolitical conflict.</li>
<li>CVR Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) stock gained 14.83% last week after the strength of the oil market lifted energy shares broadly.</li>
</ol>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45940507/oracle-ast-spacemobile-and-halliburton-are-among-top-10-large-cap-gainers-last-week-june-9-13-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45940506/applovin-chewy-and-carvana-are-among-top-11-large-cap-losers-last-week-june-9-13-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">AppLovin, Chewy And Carvana Are Among Top 11 Large Cap Losers Last Week (June 9-13): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?

U.S. stocks were lower, with the Dow Jones index falling around 600 points on Friday.
Shares of Unusual Machines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#NYSE">UMAC</a>) rose sharply during Friday's session after the company agreed to acquire Rotor Lab in all-stock deal valued at $7 million. The company also announced termination of definitive<a href="https://www.benzinga.com/quote/UMAC"> agreement to acquire Aloft.</a>
Unusual Machines shares jumped 19.5% to $9.85 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) shares jumped 22.8% to $217.17 after the company reported better-than-expected first-quarter adjusted EPS results and announced it is maintaining its current FY25 guidance despite tariff and macroeconomic event uncertainty.</li>
<li>AleAnna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNA#NASDAQ">ANNA</a>) gained 18.3% to $10.40.</li>
<li>Columbus Circle Capital Corp I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCM#NASDAQ">CCCM</a>) rose 13.5% to $11.95.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) surged 11.4% to $35.08.</li>
<li>Maase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAAS#NASDAQ">MAAS</a>) rose 11.1% to $3.00.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) gained 10.8% to $5.38.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) climbed 9.9% to $22.36 as the company announced 76-week results from Barzolvolimab Phase 2 study in chronic spontaneous urticaria at EAACI Congress 2025.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) rose 8.4% to $12.01. UroGen Pharma shares traded higher on Thursday after the FDA approved ZUSDURI for intravesical solution as the first and only medication for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.</li>
<li>DoubleDown Interactive Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) gained 6.9% to $8.71. DoubleDown Interactive recently announced the pricing of its secondary offering of 4,347,827 ADS by selling shareholders at $8.50 per ADS.</li>
<li>Kosmos Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) gained 6.7% to $2.2309.</li>
<li>Phathom Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) gained 5.5% to $10.58.</li>
<li>Bunge Global SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) rose 5% to $80.89.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45924005/top-2-energy-stocks-that-may-fall-off-a-cliff-in-june">Top 2 Energy Stocks That May Fall Off A Cliff in June</a> </li>
</ul>
Photo via Shutterstock

ANNA

CCCM

CLDX

Highest Performances Holdings Inc. - American Depository Shares

MAAS

PHAT

UMAC

Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday

Darling Ingredients Announces Dual Listing Of Its Common Stock On NYSE Texas; To Trade Under 'DAR' On NYSE Texas

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) and Tessenderlo Group disrupted the enormously profitable health, wellness and nutrition industry this week, <a href="https://www.benzinga.com/pressreleases/25/05/b45340702/darling-ingredients-and-tessenderlo-group-agree-to-form-new-company-to-accelerate-growth-in-attrac">announcing an agreement</a> to merge the collagen and gelatin units of their waste recovery operations into the newly formed Nextiva. Darling already produces 30% of the world's collagen supply, while the joint venture could generate up to $1.5 billion in revenue in its first year of operation.&nbsp;
Nextiva will sit in collagen's sweet spot, with industry growth forecast to rise 9.5% annually, reaching over $14 billion in 2033. This biological gold is extracted from animal skin, tendon, cartilage and bone that waste recovery companies used to throw away as useless byproduct. Its popularity in cosmetics, joint health, supplements, biomaterials and pharmaceuticals has exploded in the last decade, with anti-aging and skin health benefits touted by Jennifer Aniston, Kate Hudson, Kourtney Kardashian and other celebrities.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Texas-based Darling has struggled in the last two years, with annual revenue dropping from $6.79 billion in fiscal 2023 to $5.22 billion in fiscal 2024. This marked the first revenue downturn for the S&amp;P Mid Cap 400 component since 2019. The hookup is a strategic move to respond to Wall Street about declining performance and regrow earnings by leveraging its leadership in the profitable animal byproducts segment.&nbsp;
Top tier investment firms including Piper Sandler, <a href="https://www.benzinga.com/markets/25/04/45039081/td-cowen-says-twenty-one-reflects-most-meaningful-validation-of-strategys-bitcoin-treasury-operation">TD Cowen</a>, and UBS cover Darling stock but have yet to issue research reports on this week's news. Clearly, their endorsements will help the deal proceed without roadblocks. In late April, Jason Gabelman at TD Cowen lowered his Darling price target from $37 to $34, pointing to an inconsistent track record on guidance. His ‘take' on the new venture will be watched closely by Wall Street.
Chairman and CEO Randall C. Stuewe touted the venture, saying, &#8220;Collagen has represented the fastest-growing area of <a href="https://www.benzinga.com/insights/earnings/25/04/44962097/what-to-expect-from-darling-ingredientss-earnings">Darling Ingredients</a>&#8216; food segment business over the past several years.&#8221; He added that the joint venture will provide a "platform for accelerated product development and growth" and create an opportunity to "unlock significant shareholder value." Darling will own 85% of Nextiva, according to the release, while its Brussels partner holds the balance. Together they intend to operate 23 facilities on four continents, producing about 200,000 tons of collagen and gelatin in the first year.&nbsp;
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
The hookup is not expected to close until 2026. The initial press release describes the venture as a noncash transaction that combines assets and capabilities, but negotiations are continuing, and no definitive documentation has been sign by principals. However, the ownership ratio between the much larger Darling and its smaller partner appears locked-in and there are no obvious red flags to the startup currently.
Nextiva will also require regulatory approval in the U.S. and European Union, which might face unexpected hurdles, given current political tensions. Meanwhile, collagen use remains unregulated and somewhat controversial, <a href="https://www.health.harvard.edu/blog/considering-collagen-drinks-and-supplements-202304122911">with critics noting the refined product</a> used in supplements breaks down when ingested, rather than rebuilding our naturally produced substance. They also point to the corruptive influence of marketing hype, driven by celebrities owning companies benefiting from collagen use.
Regardless, both critics and advocates consider collagen use to be safe and our beauty-obsessed culture has a long history of chasing the latest ‘Fountain of Youth', regardless of cost. This bodes well for Darling and Tessenderlo's profit growth in coming years. And, given their giant industry footprint, they could strongly influence worldwide supply and pricing in coming decades.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a></li>
</ul>
Image: Shutterstock

New Wellness JV Nexida Aims to Tackle Aging—And They're Backed by a Third of the World's Collagen Supply

<ul>
<li>Creates ~$1.5 billion revenue company in fast-growing collagen-based health, nutrition and food sectors</li>
<li>85% owned and consolidated by Darling Ingredients</li>
<li>Non-cash transaction, combining assets, capabilities</li>
<li>Strengthens foundation around serving food and pharma customers</li>
<li>Provides a platform for accelerated product development and growth</li>
<li>Creates an opportunity to unlock significant shareholder value</li>
</ul>

Darling Ingredients (85%) And Tessenderlo Group (15%) To Merge Collagen Units Into $1.5B Global Venture Nextida

Baird analyst Ben Kallo maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Outperform and lowers the price target from $41 to $40.

Price Target

Analyst Ratings

Baird Maintains Outperform on Darling Ingredients, Lowers Price Target to $40

Darling Ingredients Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) shares are <a href="https://www.benzinga.com/movers">trading lower on Thursday</a> after the first-quarter FY25 earnings.
The company reported a <a href="https://www.benzinga.com/pressreleases/25/04/b44974440/darling-ingredients-inc-reports-first-quarter-2025-results">first-quarter sales decline of 2.8%</a> year-on-year to $1.38 billion, missing the analyst consensus estimate of $1.45 billion.
Adjusted EPS of the loss of 16 cents <a href="https://www.benzinga.com/earnings">missed the consensus </a>estimate of 40 cents.
Total costs and expenses decreased 2.9% to $1.32 billion. The operating income plunged 79% to $28.4 million with an operating margin of 2.1%.
Combined Adjusted EBITDA slumped 30% to $195.8 million. Darling &nbsp;repurchased about 1 million shares of its common stock during the quarter for $35 million.
Also Read: <a href="https://www.benzinga.com/news/25/04/44961625/fda-targets-synthetic-food-dyes-in-sweeping-nutrition-overhaul">FDA Targets Synthetic Food Dyes In Sweeping Nutrition Overhaul</a>
The company held $81.5 million in cash and equivalents as of March 29.
&#8220;While the biofuel environment continues to adjust, margins have started to improve. The positive narrative surrounding renewable fuels public policy is encouraging, which is also driving strong market demand for domestic fats,&#8221; said Chairman and CEO Randall C. Stuewe. 
&#8220;We expect our core business to continue to perform well, generating cash and allowing us to continue to de-lever the balance sheet and opportunistically repurchase shares.&#8221;
Outlook: Darling anticipates the core business will generate approximately $950 million to $1 billion EBITDA in FY25.
The company reaffirmed guidance of $1.25 billion &#8211; $1.30 billion combined adjusted EBITDA.
Price Action: DAR shares traded higher by 0.61% at $30.50 at last check Thursday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44963985/automakers-are-struggling-with-tariffs-and-ev-competition-say-analysts">Automakers Are Struggling With Tariffs And EV Competition, Say Analysts</a></li>
</ul>
Image: Shutterstock

General

Darling Ingredients Q1: Sales Dip, EPS Miss, Margin Shrink And More

Earnings

Darling Ingredients CEO Says 'Despite the broader challenges faced by the biofuel industry during the first quarter of 2025, Darling Ingredients' core business performed well'

Guidance

Darling Ingredients Sees FY25 Core Business Generating ~$950M-$1B EBITDA

Earnings Misses

Darling Ingredients Q1 EPS $(0.16) Misses $0.40 Estimate, Sales $1.38B Miss $1.45B Estimate

ADXN

ALEX

ALLE

AMAL

AMBP

APOG

APPF

BAFN

BCPC

BELFA

BELFB

BFST

BHLB

BWMX

CBRE

CIVB

CMCSA

CNOB

COUR

CUBI

CURB

DAIO

DGICA

DGICB

ERIE

FARO

FBIZ

FCFS

FCNCA

FFBC

FRME

GBCI

GILD

GLPI

GNFT

GOOG

GOOGL

HELE

HFWA

IBCP

INDV

INTC

ITGR

KNSL

KRNY

LADR

LYTS

MBLY

MGRC

MMSI

MOFG

Earnings Scheduled For April 24, 2025

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) is set to give its latest quarterly earnings report on Thursday, 2025-04-24. Here's what investors need to know before the announcement.
Analysts estimate that Darling Ingredients will report an earnings per share (EPS) of $0.23. 
The market awaits Darling Ingredients's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.15, leading to a 3.25% increase in the share price the following trading session.
Here's a look at Darling Ingredients's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.48</td>
<td>0.40</td>
<td>0.45</td>
<td>0.5</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.63</td>
<td>0.11</td>
<td>0.49</td>
<td>0.5</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>4.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745434928_0.png" alt="eps graph" />
<h3>Market Performance of Darling Ingredients's Stock</h3>
Shares of Darling Ingredients were trading at $30.66 as of April 22. Over the last 52-week period, shares are down 32.79%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Observations about Darling Ingredients</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Darling Ingredients.
Analysts have provided Darling Ingredients with 4 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $45.25, suggesting a potential 47.59% upside.
<h3>Analyzing Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Ingredion, Limoneira and Bunge Global, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Ingredion, with an average 1-year price target of $150.0, suggesting a potential 389.24% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Limoneira, with an average 1-year price target of $23.0, suggesting a potential 24.98% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Bunge Global, with an average 1-year price target of $80.75, suggesting a potential 163.37% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Ingredion, Limoneira and Bunge Global, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Darling Ingredients</td>
<td>Buy</td>
<td>-12.17%</td>
<td>$333.76M</td>
<td>2.28%</td>
</tr>
<tr>
<td>Ingredion</td>
<td>Neutral</td>
<td>-6.30%</td>
<td>$449M</td>
<td>2.41%</td>
</tr>
<tr>
<td>Limoneira</td>
<td>Neutral</td>
<td>-13.66%</td>
<td>$-365K</td>
<td>-1.80%</td>
</tr>
<tr>
<td>Bunge Global</td>
<td>Neutral</td>
<td>-9.33%</td>
<td>$1.08B</td>
<td>6.01%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Darling Ingredients ranks at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. However, it ranks in the middle for Return on Equity.
<h3>Get to Know Darling Ingredients Better</h3>
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
<h3>Darling Ingredients: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Decline in Revenue: Over the 3 months period, Darling Ingredients faced challenges, resulting in a decline of approximately -12.17% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Darling Ingredients's net margin is impressive, surpassing industry averages. With a net margin of 7.19%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Darling Ingredients's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.28% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Darling Ingredients's ROA excels beyond industry benchmarks, reaching 0.99%. This signifies efficient management of assets and strong financial health.
Debt Management: Darling Ingredients's debt-to-equity ratio surpasses industry norms, standing at 0.97. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<a href="https://www.benzinga.com/quote/DAR/earnings">To track all earnings releases for Darling Ingredients visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from Darling Ingredients's Earnings

BRBR

CART

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

CELH

CHEF

COKE

FIZZ

FRPT

HNST

LFVN

LOCL

MGRX

PFGC

SISI

SMPL

USFD

Shares of companies within the broader consumer staples sector are trading lower amid overall market weakness.

During the last three months, 4 analysts shared their evaluations of Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Darling Ingredients and provided 12-month price targets. The average target is $45.25, accompanied by a high estimate of $52.00 and a low estimate of $41.00. Observing a downward trend, the current average is 4.39% lower than the prior average price target of $47.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725634_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Darling Ingredients by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Thomas Palmer &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $44.00&#x7C;$45.00 &#x7C; 
&#x7C;Ben Kallo &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $41.00&#x7C;$51.00 &#x7C; 
&#x7C;Thomas Palmer &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $44.00&#x7C;$46.00 &#x7C; 
&#x7C;Pooran Sharma &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $52.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Darling Ingredients. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darling Ingredients compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Darling Ingredients's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Darling Ingredients's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Darling Ingredients analyst ratings.</a>
<h2>Delving into Darling Ingredients's Background</h2>
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
<h3>Darling Ingredients's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3M period, Darling Ingredients faced challenges, resulting in a decline of approximately -12.17% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Darling Ingredients's net margin excels beyond industry benchmarks, reaching 7.19%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.28%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Darling Ingredients's ROA excels beyond industry benchmarks, reaching 0.99%. This signifies efficient management of assets and strong financial health.
Debt Management: Darling Ingredients's debt-to-equity ratio stands notably higher than the industry average, reaching 0.97. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Darling Ingredients: Insights From 4 Analyst Reviews

Citigroup analyst Thomas Palmer maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Buy and lowers the price target from $45 to $44.

Citigroup Maintains Buy on Darling Ingredients, Lowers Price Target to $44

Baird analyst Ben Kallo maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Outperform and lowers the price target from $51 to $41.

Baird Maintains Outperform on Darling Ingredients, Lowers Price Target to $41

COTY

Shares of companies within the broader consumer staples sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Press Releases

Darling Ingredients Inc. Converts Wastewater Emissions Into Renewable Natural Gas, Cutting Scope 1 Emissions

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Darling Ingredients Inc. (NYSE: DAR) and Encourages Long-Term Shareholders to Contact the Firm

Darling Ingredients Elects Soren Schroder to Board of Directors

Darling Ingredients Issues Statement on Tariffs

Darling Ingredients Inc. to Release First Quarter 2025 Financial Results

Darling Ingredients Inc. Reports First Quarter 2025 Results

Darling Ingredients Inc. to Participate in BMO Global Farm to Market Conference

Darling Ingredients and Tessenderlo Group Agree to Form New Company to Accelerate Growth in Attractive Collagen-Based Health, Wellness and Nutrition Sector

Darling Ingredients Inc. Announces Dual Listing on NYSE Texas

Darling Ingredients Inc. announces offering of €750 Million of senior notes by Darling Global Finance B.V. and proposed entry into a new amended and restated credit agreement

Archer-Daniels-Midland Company Common Stock

Archer-Daniels-Midland

AgriFORCE Growing Systems Ltd. - Common Shares

AgriFORCE Growing Systems

Alico

Bunge Global

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Cresud SACIF

Edible Garden AG Incorporated - Common Stock

Edible Garden

Fresh Del Monte Produce, Inc. Common Stock

Fresh Del Monte Produce

Ingredion

Limoneira

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras

Local Bounti

Arcadia Biosciences

S&W Seed

Sadot Group

Origin Agritech Limited - Ordinary Shares

Origin Agritech

Baird

Citigroup

Stephens & Co.

JP Morgan

Jefferies

지난주 상승한 주요 중형주 중 대부분은 중동 갈등으로 인해 유가가 급등하면서 상승한 에너지 주식이었다.
<ol class="wp-block-list">
<li>오클로(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) 주가는 26.59% 상승했다. 회사가 미 공군 기지에 깨끗한 전력을 공급하기 위해 방위물자청 에너지로부터 <a href="https://www.benzinga.com//node/45909275" target="_blank" rel="noopener">낙찰의향서</a>를 받았기 때문이다. 또한 4억 달러를 자본 조달을 통해 확보했으며, 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/OKLO/analyst-ratings" target="_blank" rel="noopener">목표주가를 상향 조정</a>했다.</li>
<li>바슈 헬스 컴퍼니즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) 주가는 지난 주 25.63% 상승했다.</li>
<li>퀀텀 컴퓨팅(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) 주가는 지난 주 21.75% 상승했다. 이는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO 젠슨 황이 <a href="https://www.benzinga.com//node/45889749" target="_blank" rel="noopener">양자 컴퓨터</a>가 곧 고전 컴퓨팅을 넘어 실제 문제를 해결할 것이라고 언급하면서 양자 관련 주식에 대한 관심이 높아졌기 때문이다.</li>
<li>트랜스오션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) 주가는 중동에서의 지정학적 긴장감이 고조되면서 유가 상승으로 인해 지난 주 20.29% 상승했다.</li>
<li>MP 머티리얼스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) 주가는 트럼프 행정부가 <a href="https://www.benzinga.com//node/45846703" target="_blank" rel="noopener">냉전 시대</a>의 권한을 발동하여 희토류 프로젝트를 가속화할 계획이라는 보도 이후 지난 주 18.87% 상승했다.</li>
<li>사솔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) 주가는 지난주 18.48% 상승했다.</li>
<li>달링 인그리디언츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) 주가는 지난주 17.11% 상승했다.</li>
<li>시비타스 리소시스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) 주가는 유가 급등과 중동 불안으로 인해 에너지 부문 모멘텀에 힘입어 지난주 16.77% 상승했다.</li>
<li>PBF 에너지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) 주가는 유가 상승과 지정학적 갈등 속에서 에너지 주식이 랠리를 펼친 덕분에 지난 주 15.41% 상승했다.</li>
<li>CVR 에너지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) 주가는 유가 상승의 힘 덕분에 에너지 주식이 전반적으로 상승하면서 지난주 14.83% 상승했다.</li>
</ol>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Darling Ingredients

뉴스

에 대한 최신 뉴스 Darling Ingredients (NYSE:DAR) 주식

일요일, 6월 15, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌